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Age-matched reference values for lymphocyte subpopula-
tions are generally obtained via cross-sectional studies, whereas
patients are followed longitudinally. We performed a detailed
longitudinal analysis of the changes in lymphocyte subpopula-
tions in a group of 11 healthy infants followed from birth up to
1 y of age, with special attention for early developmental mark-
ers, markers of maturation, and markers of activation. We found
that T and B lymphocytes increased at 1 and 6 wk of age,
respectively. In contrast, NK cells showed a sharp decline di-
rectly after birth, suggesting that they are more important during
pregnancy than thereafter. CD45RA1—mainly CD41—naive T
lymphocytes were high at birth, and increased further during the
first year of life; they form a large expanding pool of cells, ready
for participation in primary immune responses. The absolute
counts of CD45RO1 memory T lymphocytes were similar in
infants and adults, albeit with a lower level of expression of
CD45RO on infant T lymphocytes. Almost all infant T lympho-
cytes expressed CD38 throughout the first year of life. The
abundant expression of CD38 on an infant’s T lymphocytes
might be related to a greater metabolic need of the large popu-
lation of naive untriggered cells that are continually involved in
primary immune responses during the first year of life. The high
B lymphocyte counts in infants mainly concerned CD381 B
lymphocytes throughout the first year of life. Also, the relative
frequencies of CD1c1 and CD51 B lymphocytes were higher
throughout the first year of life than in adults. Therefore, CD1c,
CD5, and CD38 could be markers of untriggered B lymphocytes.
In conclusion, our longitudinal survey of T and B lymphocytes,
NK cells, and their subpopulations during the first year of life
helps to complete the picture of lymphocyte development in
infants. This information contributes to the correct interpretation
of data from infants with possible immune disorders. (Pediatr
Res 47: 528–537, 2000)
Abbreviations
CD4/CD8, ratio between helper and suppressor T lymphocytes
NK, natural killer
TCR, T cell receptor
Immunophenotyping of blood lymphocyte subpopulations is
an important tool in the diagnosis and follow-up of children
with immune disorders. Correct interpretation of the obtained
results requires knowledge of the normal development of the
immune system during the first years of life.
For this purpose, several sets of age-matched reference
values of relative frequencies and absolute counts of lympho-
cyte subpopulations in childhood have been reported (1–5).
Because of the higher blood lymphocyte counts in neonates
and infants compared with adults (1, 6), differences in lym-
phocyte subpopulations are better reflected by comparison of
absolute counts than relative frequencies. In that way, trends
are observed that are missed when only relative frequencies are
used (1). These absolute lymphocyte counts are more accu-
rately determined by the lysed whole blood technique than by
analysis after density gradient separation (7, 8).
To date, age-matched reference values for lymphocyte sub-
populations were all obtained in cross-sectional studies. Lon-
gitudinal studies in individual children are more informative
about the pattern of lymphocyte subpopulation development as
a function of time. Children with immune disorders are also
followed longitudinally. Therefore, it is useful to compare
patient data with data from studies on longitudinal develop-
ment of lymphocyte subpopulations in healthy children. Such
longitudinal follow-up studies can also assess the influence of
factors such as infection and vaccination on the size of lym-
phocyte subpopulations. This information is important for
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correct timing of lymphocyte subpopulation studies for diag-
nostic purposes as well as for disease monitoring in patients.
We therefore performed a detailed longitudinal analysis of
lymphocyte subpopulations by immunophenotyping with a
lysed whole blood microassay in a group of 11 healthy infants
followed from birth to 1 y of age. We studied helper and
cytotoxic T lymphocytes, B lymphocytes, NK cells, and their
subpopulations. Because the presence of immature as well as
of activated cells has been described in neonatal samples in the
past (9), special attention was paid to the expression of early
developmental markers, markers of maturation, and markers of
activation.
METHODS
Subjects and cell samples. Immediately after clamping of
the cord, neonatal cord blood was collected by venipuncture
from 11 healthy infants born after an uncomplicated pregnancy
and delivery at gestational ages of 35 wk (infant 10), 37 wk
(infant 6), 38 wk (infant 4), 40 wk (infants 2, 3, 9, and 11), and
41 wk (infants 1, 5, 7, and 8). At the age of 7 d, 6 wk, 3 mo,
6 mo, and 1 y, additional blood samples were collected by
venipuncture from the same infants (infant 11 was lost to
follow-up at 6 mo of age). The blood was kept at room
temperature until immunostaining was performed within 12 h
after sampling. Every time a blood sample was taken, a phys-
ical examination of the infant was performed by the pediatri-
cian (E.d.V.), and questions about infections, vaccinations,
feedings, and development were answered by the mother.
Adult peripheral blood was drawn by venipuncture from nine
healthy adult volunteers (age, 20 to 40 y). EDTA was used as
anticoagulant. Informed consent was obtained according to the
guidelines of the Medical Ethics Committee of the Erasmus
University Rotterdam/University Hospital Rotterdam.
Flow cytometric analysis. The MAb used in 30 triple label-
ings (listed in Table 1) were conjugated with FITC, phyco-
erythrin, or the duochrome phycoerythrin-cyanin 5. The same
set of 30 triple immunostainings was used in all samples to
enable accurate comparison of the relative and absolute sizes of
the different T lymphocyte (CD31), B lymphocyte (CD191),
and NK cell (CD32/CD161 or CD561 or both) subpopulations
between the infants at the various times in their first year of life
and the adults.
A lysed whole blood microassay was used for all stainings as
described previously (10). Briefly, 20 mL of blood was incu-
bated with three optimally titrated MAb for 10 min at room
temperature. Erythrocytes were lysed with Lysing Solution
(Becton Dickinson, San Jose, CA). The CD71/glycophorin
A/CD45 triple immunostaining was included to identify nor-








IgG1 IgG1 (BD) IgG2 IgG2 (BD) IgG1 679.1Mc7 (IT)
CD15 CLB-gran2 (CLB) CD14 My-4 (CT) CD45 HI30 (PH)
CD71 66IG10 (MS) GpA D2.10 (PH) CD45 HI30 (PH)
CD37 IOB1 (IT) CD20 Leu-16 (BD) CD19 HIB19 (PH)
CD5 Leu-1 (BD) CD19 Leu-12 (BD) CD3 Hit3a (PH)
CD38 IOB6 (IT) CD45RA 2H4 (CT) CD19 HIB19 (PH)
CD3 Leu-4 (BD) CD1a T6 (CT) CD19 HIB19 (PH)
CD1c 7C6 (KM) CD19 Leu-12 (BD) CD3 Hit3a (PH)
CD25 2A3 (BD) CD19 Leu-12 (BD) CD3 Hit3a (PH)
CD71 66IG10 (MS) CD19 Leu-12 (BD) CD3 Hit3a (PH)
CD4 Leu-3a (BD) CD8 Leu-2a (BD) CD3 Hit3a (PH)
TCRab WT31 (BD) CD4 Leu-3a (BD) CD3 Hit3a (PH)
TCRab WT31 (BD) CD8 Leu-2a (BD) CD3 Hit3a (PH)
TCRgd TCRd1 (TD) CD4 Leu-3a (BD) CD3 Hit3a (PH)
TCRgd TCRd1 (TD) CD8 Leu-2a (BD) CD3 Hit3a (PH)
CD4 Leu-3a (BD) CD45RA 2H4 (CT) CD3 Hit3a (PH)
CD8 Leu-2a (BD) CD45RA 2H4 (CT) CD3 Hit3a (PH)
CD4 Leu-3a (BD) CD45RO UCHL-1 (DK) CD3 Hit3a (PH)
CD8 Leu-2a (BD) CD45RO UCHL-1 (DK) CD3 Hit3a (PH)
CD45RO UCHL-1 (DK) CD45RA 2H4 (CT) CD3 Hit3a (PH)
CD38 IOB6 (IT) CD45RO UCHL-1 (DK) CD3 Hit3a (PH)
CD38 IOB6 (IT) CD45RA 2H4 (CT) CD3 Hit3a (PH)
CD57 Leu-7 (BD) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD7 CLB3A1/1 (CLB) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD8 Leu-2a (BD) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD38 IOB6 (IT) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD45RO UCHL-1 (DK) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD45RA Leu-18 (BD) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
CD25 2A3 (BD) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
HLA-DR L243 (BD) CD16/CD56 Leu-11c/Leu-19 (BD) CD3 Hit3a (PH)
Abbreviations: PE, phycoerythrin; PE-Cy5, phycoerythrin-cyanin 5.
* Companies: BD 5 Becton Dickinson, San Jose, CA; CLB 5 Central Laboratory of the Blood Transfusion Service, Amsterdam, the Netherlands; MS 5
Monosan Sanbio, Uden, the Netherlands; IT 5 Immunotech, Marseille, France; KM 5 Dr. W. Knapp and Dr. O. Madjic, Vienna, Austria; TD 5 T-cell
diagnostics, Cambridge, MA; DK 5 Dakopatts, Glostrup, Denmark; CT 5 Coulter Clone, Hialeah, FL; PH 5 Pharmingen, San Diego, CA.
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moblasts and unlysed erythrocytes within the lympho-gate,
which was defined on the forward and side scatter patterns of
lymphocytes (10). The samples were analyzed with a FACScan
flow cytometer, using FACScan Research software (Becton
Dickinson, San Jose, CA).
Lymphocyte count and differentiation. The total nucleated
cell count was determined on an H1 Technicon hemocytometer
(Bayer, Tarrytown, NY). The relative frequency of normo-
blasts was determined by manual differentiation of 400 nucle-
ated cells in all samples. The total lymphocyte count was
determined according to the following formula:
total nucleated cell count 3
(100 2 % of normoblasts) 3 (% of lymphocytes) 3 1024
Lymphocyte subpopulations were calculated according to the
following formula:
% of population within the lympho-gate
100 2 (% of normoblasts plus unlysed
erythrocytes within the lympho-gate)
3 102
Statistics. After applying logarithmic transformation to ob-
tain approximately normally distributed variables, repeated
measurements ANOVA was used to compare the various
sampling times. Additional specific comparisons were made
for T lymphocytes, NK cells, and their subpopulations in cord
blood versus the mean of these variables at the other sampling
times. Also, for B lymphocytes and their subpopulations, the
mean of cord blood and blood drawn at 1 wk was compared
with the mean of the sampling times thereafter. To evaluate the
effects of infection, vaccination, medication, and breast-
feeding at the various sampling times, the t test was used for
each factor. In view of the number of comparisons made, the
significance level was set at p , 0.01.
RESULTS
Subject follow-up. All infants were born after a normal
pregnancy and delivery. All had birth weights appropriate for
gestational age. None of the infants used medication at any
time when a blood sample was taken. Several infants suffered
from minor infections of the upper airways or gastrointestinal
tract around the time a blood sample was taken. One infant had
atopic eczema and food allergies (infant 5). No other medical
problems were noted. The infants were vaccinated according to
the regular Dutch schedule, which consisted of diphtheria
toxoid, tetanus toxoid, pertussis, and inactivated polio virus
type I, II, and III (DTP-IPV) at 3, 4, 5, and 11 mo of age at the
time of the study.
Lymphocyte counts. Total lymphocyte counts and T lym-
phocyte counts increased at 1 wk of age. B lymphocyte counts
increased at 6 wk of age. NK cells followed a different pattern:
they were highest at birth and decreased at 1 wk of age (Fig. 1
and Tables 2-4).
TCR expression on T lymphocytes. Most T lymphocytes
expressed the ab TCR (Table 5). TCRgd1 T lymphocyte
counts increased slightly during the first year of life (Table 2).
Expression of CD4 and CD8 on T lymphocytes. CD41
helper T lymphocyte counts followed the pattern of total T
lymphocyte counts with an increase at 1 wk of age, as did
CD81 cytotoxic T lymphocyte counts (Table 2). Although both
CD41/CD31 and CD81/CD31 counts were higher in infants
than in adults, the CD4/CD8 ratio was higher in infants than in
adults, because of the very high CD41/CD31 counts in infants
(Tables 2 and 5).
Paucity of thymocyte-like T cells. In the thymus, CD41/
CD81 double-positive T cells develop into single-positive
CD41 or CD81 T lymphocytes (11), and CD1a is a marker
present on cortical thymocytes (12). Hardly any CD41/CD81
double-positive or CD1a1 T cells were present in the blood of
either infants or adults (Fig. 2, A–D, and Tables 2 and 5).
CD45 isoform expression on T lymphocytes. The relative
expression of the CD45RA and CD45RO isoforms was pro-
foundly different between infants and adults: the median rela-
tive frequencies of CD45RA1 naive T lymphocytes were
higher, and the median relative frequencies of CD45RO1
memory T lymphocytes were lower, in infants than in adults
(Table 5), as was described before (3–5, 13). However, the
median absolute counts of CD45RO1 memory T lymphocytes
were similar in infants and adults, with a slight increase at 1 wk
of age (Table 2). The changes in the absolute counts of T
lymphocytes during the first year of life were mainly accounted
for by changes in the size of the CD45RA1 naive T lympho-
Figure 1. T lymphocytes, B lymphocytes, and NK cells from birth to 1 y of age. Each graph represents one individual infant (infants 1–10).
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cyte population, not by changes in the size of the CD45RO1
memory T lymphocyte population in the course of time (Figs.
3 and 4). However, the intensity of CD45RO staining was
higher in adults than in infants, i.e. adult T lymphocytes
probably carried more CD45RO molecules on their cell surface
(Fig. 2, E and F).
The increase in CD45RA1 naive T lymphocytes during the
first year of life and the slight increase of CD45RO1 memory
T lymphocytes at 1 wk of age was caused by an increase in
CD41 helper T lymphocytes as well as CD81 cytotoxic T
lymphocytes (Tables 2 and 5).
Expression of CD38 on T lymphocytes. We found CD38 on
$90% (median) of T lymphocytes in infants, and on about half
of adult T lymphocytes (Fig. 2, G and H, and Table 5).
The distribution of CD38 on CD45RA1 naive and
CD45RO1 memory T lymphocytes was markedly different
between infants and adults (Table 5). In adults, the CD381/
CD45RA1/CD31 and the CD381/CD45RO1/CD31 subpopu-
lations were much smaller, and the CD382/CD45RA1/CD31
and the CD382/CD45RO1/CD31 subpopulations were much
larger, than in infants. The changes in size of the CD45RA1
naive T lymphocyte subpopulation in the first year of life were
Table 2. Absolute counts of lymphocytes, CD31 T lymphocytes, and CD31 T lymphocyte subpopulations in 11 infants during follow-up
from birth to 1 y of age and in nine adults
Cell type
Neonatal cord
blood 1 wk 6 wk 3 mo 6 mo 1 y p value* Adults
Total lymphocytes 4.7 (3.5–6.2)† 6.9 (4.0–9.6) 7.2 (4.1–12.6) 7.1 (5.8–9.6) 6.8 (5.6–9.9) 7.1 (4.1–8.9) ,0.001 2.1 (1.1–2.4)
CD31 T lymphocytes 2.6 (1.9–4.4) 5.6 (2.4–8.0) 5.1 (3.0–9.5) 4.5 (3.9–7.1) 4.5 (3.7–7.7) 4.4 (2.3–5.9) ,0.001 1.5 (0.7–1.8)
T cell subpopulations
TcRab1/CD31 2.5 (1.8–4.3) 5.5 (2.2–7.7) 4.9 (2.9–8.5) 4.2 (3.5–7.0) 4.2 (3.3–7.5) 4.0 (2.0–5.8) ,0.001 1.4 (0.6–1.7)
TcRgd1/CD31 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.1–0.8) 0.2 (0.1–0.3) 0.2 (0.1–0.3) 0.2 (0.1–0.3) ,0.001 0.1 (0.0–0.2)
CD41/CD31 2.0 (1.4–3.5) 4.1 (2.0–6.1) 3.3 (2.2–5.4) 3.4 (2.6–6.1) 3.5 (2.4–5.5) 3.2 (1.5–5.0) ,0.001 1.0 (0.4–1.1)
CD81/CD31 0.6 (0.5–1.0) 1.3 (0.4–2.4) 1.2 (0.7–5.8) 1.0 (0.8–1.4) 1.0 (0.5–2.2) 1.0 (0.6–1.5) ,0.001 0.5 (0.3–0.8)
CD41/CD81/CD31 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.4) 0.1 (0.0–0.2) 0.0 (0.0–0.2) 0.0 (0.0–0.2) NS 0.0 (0.0–0.1)
CD1a1/CD31 0.1 (0.0–0.3) 0.0 (0.0–0.3) 0.0 (0.0–0.5) 0.0 (0.0–0.2) 0.0 (0.0–0.0) 0.0 (0.0–0.1) NS 0.0 (0.0–0.1)
CD45RA1/CD31 1.7 (1.0–3.9) 4.3 (1.9–5.5) 3.6 (2.1–5.2) 3.8 (2.7–5.8) 3.7 (2.8–6.7) 3.8 (1.8–5.1) ,0.001 0.9 (0.3–1.1)
CD45RO1/CD31 0.6 (0.3–1.8) 1.2 (0.7–2.4) 0.9 (0.4–6.1) 1.1 (0.6–1.9) 0.8 (0.6–2.6) 0.8 (0.5–2.1) ,0.001 0.8 (0.5–1.0)
CD381/CD31 2.5 (1.8–4.3) 5.4 (2.2–7.7) 4.8 (2.9–9.3) 4.1 (3.6–7.0) 4.2 (3.3–7.4) 4.0 (2.0–5.6) ,0.001 0.7 (0.3–0.9)
CD41/CD45RA1/CD31 1.2 (0.6–3.1) 2.4 (0.1–4.0) 2.3 (1.3–4.2) 2.8 (1.9–4.8) 2.9 (1.9–4.9) 2.7 (1.1–4.3) ,0.001 0.4 (0.1–0.8)
CD81/CD45RA1/CD31 0.6 (0.4–0.8) 1.1 (0.4–1.7) 1.0 (0.6–2.5) 0.9 (0.7–1.2) 0.9 (0.5–1.9) 1.0 (0.6–1.3) ,0.001 0.3 (0.1–0.6)
CD41/CD45RO1/CD31 0.4 (0.2–1.2) 1.0 (0.1–1.9) 0.7 (0.3–2.2) 0.7 (0.4–1.6) 0.6 (0.5–2.3) 0.6 (0.4–1.5) ,0.001 0.6 (0.3–0.7)
CD81/CD45RO1/CD31 0.1 (0.1–0.5) 0.2 (0.1–0.7) 0.1 (0.1–4.8) 0.2 (0.1–0.5) 0.1 (0.1–0.7) 0.1 (0.1–0.5) 0.002 0.2 (0.2–0.4)
CD382/CD45RA1/CD31 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.0–0.2) 0.1 (0.1–0.2) 0.1 (0.1–0.2) 0.2 (0.1–0.3) ,0.001 0.4 (0.2–0.7)
CD381/CD45RA1/CD31 1.8 (1.1–3.7) 4.2 (1.9–5.4) 3.5 (2.0–5.1) 3.6 (2.4–5.8) 3.5 (2.7–6.4) 3.6 (1.6–4.9) ,0.001 0.5 (0.2–0.7)
CD382/CD45RO1/CD31 0.1 (0.0–0.2) 0.1 (0.1–0.2) 0.2 (0.1–0.3) 0.1 (0.1–0.3) 0.2 (0.1–0.4) 0.2 (0.1–0.3) ,0.001 0.6 (0.4–0.8)
CD381/CD45RO1/CD31 0.5 (0.3–1.6) 1.1 (0.6–2.2) 0.8 (0.4–6.0) 0.8 (0.5–1.5) 0.7 (0.5–2.0) 0.6 (0.3–2.1) ,0.001 0.3 (0.1–0.4)
CD382/CD41/CD31 0.1 (0.0–0.1) 0.1 (0.1–0.2) 0.2 (0.1–0.2) 0.2 (0.1–0.2) 0.2 (0.1–0.2) 0.2 (0.1–0.2) ,0.001 0.1 (0.0–0.5)
CD381/CD41/CD31 1.9 (1.3–3.5) 4.0 (1.9–6.0) 3.1 (2.2–5.3) 3.2 (2.4–6.0) 3.4 (2.3–5.4) 3.0 (1.3–4.8) 0.002 0.5 (0.2–0.8)
CD382/CD81/CD31 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.0–1.2) 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.2 (0.0–0.3) 0.001 0.1 (0.0–0.8)
CD381/CD81/CD31 0.6 (0.5–0.9) 1.3 (0.4–2.2) 1.0 (0.5–5.4) 1.0 (0.7–1.3) 0.9 (0.5–2.1) 0.8 (0.5–1.3) NS 0.1 (0.0–0.1)
CD251/CD31 0.2 (0.2–0.4) 0.7 (0.5–0.8) 0.5 (0.3–0.8) 0.4 (0.3–0.7) 0.4 (0.3–0.5) 0.3 (0.2–0.5) ,0.001‡ 0.4 (0.2–0.5)
HLA-DR1/CD31 0.2 (0.0–0.9) 0.2 (0.1–1.6) 0.2 (0.1–6.6) 0.1 (0.1–1.3) 0.1 (0.1–0.2) 0.1 (0.1–0.3) NS 0.4 (0.0–0.8)
CD571/CD31 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.8) 0.0 (0.0–0.5) 0.0 (0.0–0.3) 0.1 (0.0–0.6) NS 0.1 (0.0–0.2)
† Median absolute count followed by minimal and maximal absolute count in parentheses 3 109/L.
‡ also 1 wk . 6 wk–1 y, 6 wk . 3 mo–1 y, 3 mo . 6 mo–1 y, all p , 0.001.
* Neonatal cord blood , 1 wk, 6 wk, 1 mo, 3 mo, 6 mo, and 1 y.
Table 3. Absolute counts of CD191 B lymphocytes and CD191 B lymphocyte subpopulations in 11 infants during follow-up from birth to
1 y of age and in nine adults
Cell type
Neonatal cord
blood 1 wk 6 wk 3 mo 6 mo 1 y p value* Adults
CD191 B lymphocytes 0.8 (0.3–1.0)† 0.6 (0.3–1.7) 1.6 (0.9–2.4) 1.7 (1.4–2.0) 1.4 (1.3–2.3) 1.7 (1.2–2.8) ,0.001 0.2 (0.1–0.4)
B cell subpopulations
CD372/CD202/CD191 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) NS 0.0 (0.0–0.0)
CD1c1/CD191 0.6 (0.3–0.9) 0.5 (0.2–1.6) 1.1 (0.7–1.9) 1.2 (0.9–1.5) 0.9 (0.6–1.3) 0.9 (0.7–1.4) ,0.001 0.1 (0.0–0.1)
CD1c2/CD191 0.4 (0.2–0.9) 0.1 (0.1–0.2) 0.4 (0.2–0.9) 0.5 (0.3–0.7) 0.5 (0.4–1.2) 0.8 (0.4–1.3) ,0.001 0.2 (0.1–0.2)
CD51/CD191 0.3 (0.1–0.4) 0.3 (0.1–0.8) 0.9 (0.6–1.6) 0.8 (0.6–1.2) 0.7 (0.4–1.2) 0.7 (0.4–1.7) ,0.001 0.1 (0.0–0.1)
CD52/CD191 0.5 (0.2–0.6) 0.3 (0.1–1.0) 0.7 (0.3–1.1) 0.8 (0.4–1.3) 0.8 (0.5–1.5) 0.8 (0.6–1.8) NS 0.2 (0.1–0.3)
CD381/CD191 0.8 (0.3–1.0) 0.6 (0.3–1.7) 1.5 (0.9–2.3) 1.6 (1.3–2.0) 1.3 (1.2–2.2) 1.6 (1.2–2.6) ,0.001 0.2 (0.1–0.3)
CD382/CD191 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.1) 0.2 (0.0–0.3) NS 0.0 (0.0–0.1)
CD711/CD191 0.0 (0.0–0.4) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.1 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.0–0.1) NS 0.0 (0.0–0.1)
CD251/CD191 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.1 (0.0–0.2) 0.1 (0.0–0.1) 0.0 (0.0–0.2) 0.1 (0.0–0.2) NS 0.2 (0.0–0.5)
† Median absolute count followed by minimal and maximal absolute count in parentheses 3 109/L.
* Neonatal cord blood, 1 wk , 6 wk, 1 mo, 3 mo, 6 mo, and 1 y.
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mainly caused by changes in size of the CD381/CD45RA1/
CD31 subpopulation. The median absolute counts of CD382/
CD45RO1/CD31 T lymphocytes increased only slightly dur-
ing the first year of life. The slight peak of CD45RO1 memory
T lymphocytes at 1 wk of age was mainly caused by an
increase in CD381/CD45RO1/CD31 T lymphocytes (Table
2).
The expression of CD38 on CD41 helper T lymphocytes
and on CD81 cytotoxic T lymphocytes was also different
between infants and adults (Table 5). In adults, most CD81 T
lymphocytes were CD382, whereas about half of the CD41 T
lymphocytes could be classified as CD381. The changes in
CD41 T lymphocytes in the first year of life were mainly
caused by changes in the size of the CD381/CD41/CD31
subpopulation, not by changes in the size of the CD382/CD41/
CD31 subpopulation (Table 2).
Expression of CD25 and HLA-DR on T lymphocytes. The
absolute counts of T lymphocytes bearing CD25 (the IL-2
receptor a-chain) on their surface peaked at 1 wk of age. The
absolute counts of HLA-DR1 T lymphocytes did not. They
were lower than in adults throughout the first year of life (Table
2).
Absence of CD571 T lymphocytes. The human NK cell
antigen, CD57, is present on a subpopulation of T lympho-
cytes. It has been suggested that these cells represent previ-
ously activated T lymphocytes, which have returned to a state
Table 4. Absolute counts of CD161/561/CD32 NK cells and CD161/561/CD32 NK cell subpopulations in 11 infants during follow-up
from birth to 1 y of age and in nine adults
Cell type
Neonatal cord
blood 1 wk 6 wk 3 mo 6 mo 1 y p value* Adults
CD161/561/CD32 NK cells 1.0 (0.4–1.6)† 0.6 (0.3–1.7) 0.4 (0.2–1.1) 0.5 (0.2–1.3) 0.3 (0.2–1.4) 0.4 (0.3–0.9) ,0.001 0.2 (0.1–0.4)
NK cell subpopulations
CD71/CD161/561/CD32 0.6 (0.3–1.2) 0.5 (0.2–1.7) 0.4 (0.2–1.0) 0.4 (0.2–1.3) 0.3 (0.2–1.4) 0.4 (0.3–0.9) NS 0.2 (0.1–0.3)
CD45RA1/CD161/561/CD32 0.6 (0.3–1.2) 0.5 (0.2–1.7) 0.4 (0.2–1.0) 0.4 (0.2–1.3) 0.3 (0.2–1.4) 0.4 (0.2–0.8) NS 0.2 (0.1–0.3)
CD381/CD161/561/CD32 0.6 (0.2–1.2) 0.5 (0.2–1.7) 0.4 (0.2–1.0) 0.4 (0.2–1.3) 0.3 (0.2–1.4) 0.4 (0.3–0.9) NS 0.2 (0.1–0.3)
CD45RO1/CD161/561/CD32 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.1) NS 0.0 (0.0–0.0)
CD81/CD161/561/CD32 0.4 (0.1–0.5) 0.4 (0.1–0.8) 0.2 (0.1–0.3) 0.1 (0.0–0.4) 0.1 (0.0–0.2) 0.1 (0.0–0.2) 0.001 0.1 (0.0–0.1)
CD571/CD161/561/CD32 0.0 (0.0–0.0) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.2) 0.1 (0.0–0.2) NS 0.1 (0.0–0.2)
CD251/CD161/561/CD32 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) NS 0.0 (0.0–0.0)
HLA-DR1/CD161/561/CD32 0.0 (0.0–0.2) 0.0 (0.0–0.2) 0.1 (0.0–0.4) 0.0 (0.0–0.1) 0.0 (0.0–0.1) 0.0 (0.0–0.1) NS 0.0 (0.0–0.1)
† Median absolute count followed by minimal and maximal absolute count in parentheses 3 109/L.
* Neonatal cord blood . 1 wk, 6 wk, 3 mo, 6 mo, and 1 y.
Table 5. Relative frequencies of CD31 T lymphocytes and CD31 T lymphocyte subpopulations in 11 infants during follow-up from birth
to 1 y of age and in nine adults
Cell type
Neonatal cord
blood 1 wk 6 wk 3 mo 6 mo 1 y Adults
CD31 T lymphocytes 59 (44–76)* 79 (58–89) 71 (61–80) 69 (53–76) 72 (50–78) 65 (50–73) 72 (60–83)
T cell subpopulations
TCRab1 94 (90–97)† 97 (94–99) 96 (89–97) 95 (89–97) 95 (90–97) 92 (88–98) 93 (83–97)
TCRgd1 3 (1–4) 2 (0–3) 3 (1–9) 3 (1–6) 4 (1–6) 4 (2–8) 5 (2–15)
CD41 72 (62–82) 76 (69–87) 74 (35–84) 75 (63–86) 56 (34–64) 50 (30–62) 58 (52–69)
CD81 27 (17–35) 25 (13–31) 25 (15–61) 15 (10–34) 15 (8–32) 16 (8–34) 33 (27–46)
CD4/CD8 ratio 2.7 (1.8–5.0) 2.9 (2.3–6.5) 2.9 (0.6–5.6) 3.5 (1.8–6.6) 3.3 (2.0–7.8) 2.9 (1.8–7.0) 2.0 (1.2–2.7)
CD41/CD81 2 (1–4) 2 (1–5) 2 (1–4) 1 (1–3) 1 (0–3) 1 (0–3) 1 (1–4)
CD1a1 2 (0–7) 1 (0–5) 1 (0–5) 1 (0–4) 0 (0–1) 0 (0–1) 0 (0–2)
CD45RA1 72 (44–94) 79 (52–90) 69 (52–84) 74 (67–91) 80 (64–90) 81 (72–88) 60 (46–71)
CD45RO1 23 (10–76) 26 (16–65) 17 (9–74) 18 (14–50) 15 (13–71) 16 (9–54) 56 (48–71)
CD381 95 (92–98) 96 (95–98) 95 (91–98) 95 (90–98) 93 (89–96) 90 (87–95) 45 (34–62)
CD41/CD45RA1 70 (37–95) 76 (41–88) 65 (57–81) 79 (64–96) 82 (72–91) 80 (65–97) 49 (35–70)
CD81/CD45RA1 83 (59–99) 84 (67–97) 83 (42–93) 84 (73–99) 89 (84–94) 89 (81–100) 73 (55–80)
CD41/CD45RO1 25 (9–83) 26 (17–73) 19 (10–84) 17 (14–62) 15 (13–90) 16 (11–65) 63 (47–81)
CD81/CD45RO1 19 (7–58) 16 (5–43) 13 (4–83) 16 (7–34) 13 (5–65) 15 (7–41) 46 (38–59)
CD382/CD45RA1 4 (2–7) 3 (1–4) 3 (2–5) 3 (1–6) 4 (2–7) 5 (2–8) 43 (28–64)
CD381/CD45RA1 97 (93–98) 98 (96–99) 96 (95–98) 98 (94–98) 97 (93–98) 95 (93–98) 56 (35–72)
CD382/CD45RO1 9 (4–19) 8 (5–13) 14 (2–26) 17 (9–29) 23 (14–30) 23 (13–36) 74 (58–83)
CD381/CD45RO1 91 (81–94) 90 (87–94) 87 (74–98) 83 (71–92) 77 (71–85) 77 (64–93) 28 (16–42)
CD382/CD41 2 (1–5) 2 (1–4) 3 (2–6) 3 (2–5) 3 (2–5) 4 (2–7) 27 (17–33)
CD381/CD41 98 (94–99) 98 (94–99) 96 (93–98) 96 (92–98) 96 (92–97) 94 (90–96) 52 (42–75)
CD382/CD81 2 (1–4) 1 (1–3) 1 (1–3) 2 (0–7) 2 (0–4) 4 (1–7) 26 (15–33)
CD381/CD81 93 (90–97) 96 (92–97) 95 (90–99) 93 (85–97) 92 (84–97) 83 (77–95) 32 (21–54)
CD251 10 (6–15) 13 (10–21) 9 (8–12) 9 (8–11) 9 (6–11) 8 (6–10) 27 (19–36)
HLA-DR1 9 (1–30) 3 (1–27) 4 (2–70) 3 (2–31) 3 (2–6) 3 (2–7) 28 (3–45)
CD571 0 (0–1) 0 (0–1) 1 (0–8) 1 (0–12) 1 (0–8) 2 (1–14) 7 (2–17)
* Median relative frequency followed by minimal and maximal relative frequency between parentheses within the lymphocyte population.
† % positivity of the CD31 T lymphocyte subpopulation followed by minimal and maximal values between parentheses.
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of rest (13). CD571 T lymphocytes were virtually absent at
birth, and very low up to 6 mo of age, except for two infants
who had higher values at some, but not all, sampling times
(Tables 2 and 5).
Paucity of precursor B cells. There was no indication that B
lymphocytes leave the bone marrow at an earlier developmen-
tal stage in infants than in adults: hardly any CD372/CD202/
CD191 precursor B cells (14) were present in the samples of
either infants or adults (Tables 3 and 6).
Expression of CD1c, CD5, and CD38 on B lymphocytes.
The relative frequencies of CD1c1 and CD51 B lymphocytes
were higher in infants than in adults. CD1c1 and CD51 B
lymphocyte absolute counts followed the pattern of total B
lymphocytes during the first year of life, with high values from
6 wk of age onward. The same was observed for CD1c2 and
CD52 B lymphocyte absolute counts, although this was not
statistically significant in the latter cell type (Fig. 5, Table 3).
CD38 was present on a median of .90% of B lymphocytes
throughout the first year of life, and on a median of 82% of B
lymphocytes in adults (Table 6). CD382 B lymphocyte abso-
lute counts were low in both infants and adults (generally
,0.1 3 109/L) (Table 3).
Expression of CD25 on B lymphocytes. CD25 is a marker
of activation in B lymphocytes (15).The relative frequencies
and absolute counts of CD251 B lymphocytes were lower
during the first year of life than in adults (Tables 3 and 6).
Expression of CD71 on B lymphocytes. The transferrin
receptor CD71 is present on a subpopulation of B lymphocytes
(16). It is not clear what role CD71 has on the surface of B
lymphocytes. It might be present as a marker of activation. The
absolute counts of CD711 B lymphocytes were the same in
infants throughout the first year of life and in adults (Table 3).
It is important to note that most CD711 cells (66–95%) within
the lympho-gate of the neonatal cord blood samples were
normoblasts, as we described before (10).
CD72, CD382, and CD45RA2 NK cells. At birth, some
infants showed large subpopulations of NK cells that were not
expressing CD7, CD38, and CD45RA. At 1 wk of age, five of
11, four of 11, and three of 11 infants still did not express CD7,
CD38, and CD45RA, respectively, on .20% of their NK cells.
However, the CD72, CD382, and CD45RA2 NK cells do not
account for the high absolute NK cell counts during the first
week of life (Table 7). Only CD81 NK cells were significantly
higher at birth than thereafter (see below).
Absence of CD571 NK cells. CD57 is a well-known marker
of a subpopulation of NK cells, whose role is not yet known.
Figure 2. Expression of early developmental markers and markers of matu-
ration by T lymphocytes. Hardly any CD41/CD81 double-positive T cells
were present in neonates (A) and adults (B). CD1a was hardly expressed on T
cells at birth (C), or in adults (D). The intensity of staining of CD45RO1
memory T lymphocytes was lower in neonates (E) than in adults (F). CD38
was expressed by most T lymphocytes in neonates (G), and by about half of
adult T lymphocytes (H).
Figure 3. Absolute counts (geometric mean and SD) of CD45RA1 and
CD45RO1 T lymphocyte subpopulations 3 109/L in 11 infants during the first
year of life and in nine adults. Left bars, CD45RA1 T lymphocytes. Right bars,
CD45RO1 T lymphocytes.
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It is rapidly lost after NK cell activation (17). Interestingly,
CD57 was hardly expressed by NK cells until 3 mo of age (Fig.
6A). From 3 mo until 1 y of age, a growing number of infants
showed a CD571 NK cell subpopulation of up to approxi-
mately 20% (median) of NK cells. Adults always showed a
CD571 NK cell subpopulation (Fig. 6B, Tables 4 and 7).
Absence of CD45RO1 NK cells. The CD45RA2 NK cells in
neonatal cord blood must express another isoform of the CD45
molecule, such as CD45RB or CD45RC, inasmuch as almost
none of these NK cells were expressing the CD45RO isoform
either (Fig. 6C, Tables 4 and 7). Possibly the small but clearly
present population of CD45RO1 NK cells in adults (Fig. 6D)
represents NK cells that have encountered a stimulus, similar
to CD45RO1 memory T lymphocytes.
Expression of CD25 and HLA-DR on NK cells. CD25 is
up-regulated in NK cells on activation, as is HLA-DR (18).
CD25 and HLA-DR were hardly expressed by NK cells in
infants as well as adults (Tables 4 and 7).
Expression of CD8 on NK cells. The relative frequency of
CD81 NK cells did not change significantly during the first
year of life (Table 7), but the absolute counts of CD81 NK
cells at birth and 1 wk of age were high (Table 4). These high
CD81 NK cell counts can influence the determination of the
CD41/CD81 ratio of T lymphocytes if single immunostaining
is used instead of multiple immunostaining with CD4, CD8,
and CD3 MAb.
Influence of infections and vaccinations. Infant 1 experi-
enced her first, probably viral, upper respiratory tract infection
at 6 wk of age; she was not very ill, and recovered without
treatment within a week. None of the other infants had an
infection in the first 6 wk of life. Infant 1 had a very high T
lymphocyte count at week 6 (Fig. 1), because of an extremely
high absolute count of CD81 T lymphocytes (5.8 3 109/L); her
absolute count of CD41 T lymphocytes was not different from
that of other infants (3.3 3 109/L). Her CD45RO1 memory T
lymphocytes were high at that time (6.1 3 109/L); there was no
significant relation between the absolute count of CD45RO1
memory T lymphocytes and infection at any other time in our
small group of infants, however. Interestingly, CD251 T lym-
phocytes in infant 1 were not different from those of other
infants (9% of T lymphocytes; 0.8 3 109/L), whereas the
HLA-DR1 T lymphocyte count was very high (70% of T
lymphocytes; 6.6 3 109/L), as was the HLA-DR1 NK cell
count (40% of NK cells, 0.5 3 109/L).
At no other time was a significant relation between recent
infection or vaccination and the distribution of lymphocyte
subpopulations found in this small group of 11 infants.
DISCUSSION
After differentiation in the bone marrow and thymus, lym-
phocytes undergo further functional maturation in the periph-
ery. This process is directed by numerous encounters with
environmental antigens that take place from birth onward. The
immune system thus gradually builds up a pool of experienced
memory lymphocytes. It is to be expected that these matura-
Figure 4. CD45RA1 and CD381 T lymphocytes followed the pattern of total T lymphocytes in the infants, but CD45RO1 T lymphocytes did not. Each graph
represents one individual infant (infants 1–10).
Table 6. Relative frequencies of CD191 B lymphocytes and CD191 B lymphocyte subpopulations in 11 infants during follow-up from
birth to 1 y of age and in nine adults
Cell type
Neonatal
cord blood 1 wk 6 wk 3 mo 6 mo 1 y Adults
CD191 B lymphocytes 16 (9–21)* 10 (6–19) 22 (16–29) 23 (18–28) 22 (18–31) 28 (19–36) 12 (7–18)
B cell subpopulation
CD372/CD202 1 (0–2)† 2 (1–7) 1 (1–6) 1 (0–3) 1 (1–4) 2 (0–8) 1 (1–3)
CD51 38 (25–62) 47 (40–67) 62 (48–71) 45 (34–73) 43 (30–68) 48 (29–68) 23 (13–30)
CD1c1 85 (59–92) 87 (72–90) 75 (54–83) 69 (61–79) 64 (46–72) 55 (33–63) 25 (21–29)
CD381 99 (98–100) 98 (90–99) 98 (95–99) 97 (94–99) 94 (91–97) 93 (82–97) 82 (62–86)
CD711 7 (2–45) 9 (1–17) 2 (1–6) 3 (1–5) 3 (1–17) 3 (2–7) 8 (3–27)
CD251 2 (1–29) 6 (2–24) 4 (2–9) 3 (1–8) 3 (1–10) 4 (1–11) 13 (8–26)
* Median relative frequency followed by minimal and maximal relative frequency between parentheses within the lymphocyte population.
† % positivity within the CD191 B lymphocyte subpopulation followed by minimal and maximal values between parentheses.
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tional processes are to some extent reflected by changes in the
composition of lymphocyte subpopulations during infancy.
Reference values for lymphocyte subpopulations obtained in
cross-sectional studies may reflect this gradual process, but
changes in the composition of lymphocyte subpopulations in
individual children will not occur at exactly the same sampling
times in life, and will therefore be leveled off in such studies.
Longitudinal studies in individual children are more informa-
tive about the pattern of lymphocyte subpopulation develop-
ment as a function of time, and about the influences of external
factors, such as infections and vaccinations, on this develop-
ment. Also, children with immune disorders are generally
followed longitudinally. Therefore, we performed a longitudi-
nal survey of lymphocyte subpopulations in 11 healthy infants
during the first year of life and compared these results with
those obtained in nine adults. We did not find a significant
relation between infection or vaccination and the distribution
of lymphocyte subpopulations— except for one sampling
time—in this small group of 11 healthy infants.
We found that T and B lymphocyte counts were high
throughout the first year of life, with an increase at 1 and 6 wk
of age, respectively. In contrast, NK cell counts were high at
birth and declined after the first week of life, but remained at
levels about twice those found in adults. This is in line with
previous data obtained in a cross-sectional study, as we re-
ported recently (19).
Because of these high lymphocyte counts in infants, differ-
ences in subpopulations of T and B lymphocytes and NK cells
between infants and adults are better reflected by comparison
of their absolute counts than by comparison of their relative
frequencies. This is illustrated by our findings in T and B
lymphocyte, as well as NK cell, subpopulations.
CD41 as well as CD81 T lymphocyte counts followed the
pattern of total T lymphocytes, with an increase at 1 wk of age
and high numbers—especially of CD41/CD31 T lympho-
cytes—throughout the first year of life. These were mainly
CD45RA1 naive T lymphocytes, probably new T cells freshly
released from the thymus (20). The absolute counts of
CD45RO1 memory T lymphocytes in infants during the first
year of life and in adults were similar. Therefore, the profound
differences in relative frequencies of CD45RA1 naive and
CD45RO1 memory T lymphocytes between infants and adults
are not caused by changes in the size of the CD45RO1 memory
pool, but by changes in the size of the CD45RA1 naive pool of
T lymphocytes: a large pool of naive untriggered cells is
present at birth, and increases further during the first year of
life, ready for participation in primary immune responses.
Then how is the building of a functional memory pool of T
lymphocytes reflected in the distribution of T lymphocyte
subpopulations? First, adult T lymphocytes probably carried
more CD45RO molecules on their surface than infant T lym-
phocytes. Second, the distribution of the expression of CD38
on CD45RO1 memory (and CD45RA1 naive) T lymphocytes
was markedly different between infants and adults: it decreased
from birth to adulthood, as was described before on total T
lymphocytes (4, 21–27). CD38 is a differentiation lineage-
unrestricted cell surface molecule, with a role in cellular
adhesion, activation, and proliferation, known to be expressed
on thymocytes, activated peripheral blood T and B lympho-
cytes, and plasma cells. It is generally regarded as an activation
marker (28). However, we and others (1, 27, 29, 30) did not
find other markers of activation in neonatal cord or infant
blood, such as increased expression of CD25, HLA-DR, CD69,
and CD154 (CD40 ligand). Nor did we find an increase of
thymocyte-like CD1a1 or CD41/CD81 double-positive T
cells. We therefore presume that the abundant expression of
CD38 on infant’s T lymphocytes might be related to a greater
metabolic need of the large population of naive untriggered
cells, because of their continually required participation in
primary immune responses.
Little is known about markers expressed by naive untrig-
gered B lymphocytes. Cell surface expression of CD45 iso-
forms is not informative in B lymphocytes: all B lymphocytes
express the CD45RA isoform (31), not the CD45RO isoform
(32). We and others (16) found higher relative frequencies of
CD1c1, CD51, and CD381 B lymphocytes in neonates and
infants than in adults. The function of CD1c on the surface of
B lymphocytes has not yet been elucidated. CD51 B lympho-
cytes spontaneously produce low-affinity polyreactive IgM
autoantibodies, use unmutated genes, and are presumed to
represent a more primitive lineage than CD52 B lymphocytes
(33). We found that CD1c1 and CD51 B lymphocyte counts
were indeed higher at birth than in adults; they increased even
further during the first year of life. CD1c2 and CD52 B
Figure 5. Absolute counts (geometric mean and SD) of various B lymphocyte
subpopulations 3 109/L in 11 infants during the first year of life and in nine
adults. A, left bars, CD1c1 B lymphocytes; right bars, CD1c2 B lymphocytes.
B, left bars, CD51 B lymphocytes; right bars, CD52 B lymphocytes.
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lymphocyte counts also increased during the first year of life,
albeit this was not statistically significant for CD52 B lym-
phocyte counts. However, the relative frequencies of CD1c1
and CD51 B lymphocytes were considerably higher through-
out the first year of life than in adults. Therefore, CD1c and
CD5 could be markers of untriggered B lymphocytes. CD38 is
associated with the CD21/CD19 complex on the surface of B
lymphocytes and probably has a role as mediator of extracel-
lular signals (34). The relative frequency of CD381 B lym-
phocytes was higher in infants than in adults. CD382 B
lymphocyte absolute counts were low in infants as well as
adults; the high B lymphocyte counts throughout the first year
of life were caused by high CD381 B lymphocyte counts. The
abundant expression of CD38 on infant’s B lymphocytes could
be related to a greater metabolic need caused by the many
encounters with antigen in primary immune responses, analo-
gous to the situation in T lymphocytes.
The high NK cell counts at birth were for a large part
accounted for by CD81 NK cells. Interestingly, at birth some
infants showed large subpopulations of CD72, CD382, and
CD45RA2 NK cells. It could be that these findings are asso-
ciated with the maturational status of NK cells. However, it is
more likely that the high absolute counts of NK cells observed
directly after birth are related to a state of NK cell activation
during pregnancy, which rapidly disappears during the first
weeks after birth; these activated NK cells are postulated to
represent a fetal tumor response to maternal antigen, or to play
a role in placentation (35). This fits in with the absence of
CD571 NK cells in the first months of life: CD57 is rapidly
down-regulated on activation. CD7 is expressed on all resting
NK cells and is known to be down-regulated on activation (18).
However, we did not find an increase in the number of NK
cells positive for other activation markers at birth. CD8 is
involved in the recognition of HLA class I molecules, which
are expressed by all nucleated cells. It is intriguing that CD81
NK cells are present in such large numbers at birth. Perhaps
this is related to the maintenance of pregnancy at the immu-
nologic interface between the fetus and its mother. Interest-
ingly, the two infants born at the youngest gestational age
(infant 6 at 37 wk and infant 10 at 35 wk) showed the highest
relative frequencies and absolute counts of CD382 NK cells,
CD45RA2 NK cells, and CD72 NK cells at birth and at 1 wk
of age. CD81 NK cell absolute counts were not higher in these
two youngest children, however.
In conclusion, we showed that a detailed longitudinal anal-
ysis of the absolute counts of lymphocyte subpopulations in
infants contributes to the understanding of lymphocyte devel-
opment after birth. We found that a large pool of naive
CD45RA1—mainly CD41/CD31—T lymphocytes continues
to be produced during the first year of life, ready to be primed
in primary immune responses. With priming, further functional
maturation is accompanied by changes in the distribution of
lymphocyte subpopulations: adult memory CD45RO1 T lym-
phocytes mostly express no CD38 and probably carry more
CD45RO molecules on their surface. CD1c, CD5, and CD38
are possible markers of untriggered B lymphocytes. NK cells
Table 7. Relative frequencies of CD161/561/CD32 NK cells and CD161/561/CD32 NK cell subpopulations in 11 infants during
follow-up from birth to 1 y of age and in nine adults
Cell type
Neonatal
cord blood 1 wk 6 wk 3 mo 6 mo 1 y Adults
CD161/561/CD32 NK cells 24 (9–33)* 9 (5–31) 6 (3–9) 6 (3–18) 5 (3–19) 6 (3–11) 14 (4–18)
NK cell subpopulation
CD71 79 (38–93)† 91 (46–99) 94 (82–97) 93 (85–98) 91 (84–99) 93 (87–99) 93 (85–97)
CD45RA1 79 (40–92) 91 (50–100) 94 (86–99) 95 (92–99) 95 (83–99) 95 (87–99) 96 (93–98)
CD381 78 (38–90) 91 (65–98) 93 (84–98) 95 (86–99) 95 (81–99) 95 (87–99) 92 (79–96)
CD45RO1 0 (0–3) 1 (1–5) 6 (1–12) 4 (2–7) 7 (3–14) 5 (2–12) 2 (0–17)
CD81 37 (19–63) 36 (18–67) 36 (16–72) 36 (6–52) 26 (4–58) 19 (5–62) 29 (11–44)
CD571 0 (0–2) 0 (0–3) 0 (0–5) 0 (0–24) 12 (0–31) 20 (9–38) 47 (20–58)
CD251 1 (0–3) 2 (1–8) 3 (2–7) 4 (1–6) 4 (0–6) 1 (1–7) 5 (2–10)
HLA-DR1 2 (1–18) 6 (1–18) 14 (4–40) 12 (2–22) 10 (2–22) 8 (3–17) 10 (4–21)
* Median relative frequency followed by minimal and maximal relative frequency between parentheses within the lymphocyte population.
† % positivity within the CD161/561/CD32 NK cell subpopulation followed by minimal and maximal values between parentheses.
Figure 6. NK cell subpopulations in neonates and adults. Absence of CD571
NK cells shortly after birth (A), and a clear subpopulation of CD571 NK cells
in adults (B). Hardly any CD45RO1 NK cells were present in neonates (C), a
small subpopulation of CD45RO1 NK cells was present in adults (D).
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seem to be more important during pregnancy than thereafter,
with absolute numbers falling immediately after birth.
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